A Case of Solitary Brain Metastasis from Uterine Mullerian Adenosarcoma with Sarcomatous Overgrowth

Uterine adenosarcoma (AS) are rare tumors and have more favorable outcomes than the aggressive uterine carcinosarcomas. Uterine adenosarcoma with sarcomatous overgrowth (ASSO) is a variant form of AS and exhibits aggressive growth of tumor and the prognosis is relatively poor compared with typical AS. Usually patterns of metastasis have been known to behave like endometrial carcinoma and spread through the lymphatics. Brain metastasis from uterine AS is extremely rare. Herein, we report a case of successfully surgically removed solitary brain metastasis without any extracranial recurrence from uterine ASSO after 4 years of primary treatment.

[1]  J. Reis-Filho,et al.  Uterine adenosarcomas are mesenchymal neoplasms , 2016, The Journal of pathology.

[2]  S. Xenaki,et al.  Advanced Mesodermal (Müllerian) Adenosarcoma of the Ovary: Metastases to the Lungs, Mouth, and Brain , 2015, Case reports in surgery.

[3]  M. Munsell,et al.  Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence. , 2014, Gynecologic oncology.

[4]  H. Mackay,et al.  Uterine adenosarcomas: a dual-institution update on staging, prognosis and survival. , 2013, Gynecologic oncology.

[5]  J. Phukan,et al.  Mullerian Adenosarcoma of Uterus with Sarcomatous Overgrowth and Heterologous Component Associated with Stromal Deposit in Omentum: A Case Report and Review of the Literature , 2012, Case reports in medicine.

[6]  J. Prat,et al.  Mullerian Adenosarcoma: A Clinicopathologic and Immunohistochemical Study of 55 Cases Challenging the Existence of Adenofibroma , 2009, The American journal of surgical pathology.

[7]  U. Rudloff,et al.  Central nervous system involvement from malignant mixed Müllerian tumor (MMMT) of the uterus , 2005, Archives of Gynecology and Obstetrics.

[8]  P. Beale,et al.  Malignant mixed mullerian tumour of the ovary: Prognostic factor and response of adjuvant platinum‐based chemotherapy , 2003, The Australian & New Zealand journal of obstetrics & gynaecology.

[9]  T. Krivak,et al.  Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival. , 2001, Gynecologic oncology.

[10]  E. Yıldız,et al.  Mullerian adenosarcoma of the uterus associated with tamoxifen therapy , 2000, Archives of Gynecology and Obstetrics.

[11]  J. Ironside,et al.  Cerebral metastasis from a malignant mixed Müllerian tumour of the uterus , 1993, Histopathology.

[12]  E. Yordan,et al.  Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group study , 1993, Cancer.

[13]  T. Kaku,et al.  Adenosarcoma of the Uterus: A Gynecologic Oncology Group Clinicopathologic Study of 31 Cases , 1992, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[14]  P. Clement,et al.  Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. , 1990, Human pathology.

[15]  P. Clement,et al.  Müllerian adenosarcoma of the uterus: A clinicopathologic analysis of ten cases of a distinctive type of müllerian mixed tumor , 1974, Cancer.

[16]  N. Myong,et al.  Biopsy-proven cerebellar metastasis from a malignant mixed mullerian tumor (MMMT) of the uterus: case report. , 2009, European journal of gynaecological oncology.

[17]  Kim Jk,et al.  Biopsy-proven cerebellar metastasis from a malignant mixed mullerian tumor (MMMT) of the uterus: case report. , 2009 .

[18]  L. Selvaggi,et al.  Central nervous system involvement secondary to metastatic mixed müllerian tumor of the uterus. , 1997, Gynecologic and Obstetric Investigation.